Who owns C4 THERAPEUTICS INC?
- Ticker: CCCC
- CUSIP Number: 12529r107
Tip: Access positions for across all investors
Analyze quarterly positions in C4 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of C4 Therapeutics stock
Who bought or sold C4 THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 4.9M | $40M | 0% | Mar 2024 |
|
| Daniel D. Thurber | 4.3M | $35M | -39% | Mar 2024 |
|
| Lynx1 Capital Management | 3.6M | $30M | 16% | Mar 2024 |
|
| Commodore Capital | 3.4M | $28M | -10% | Mar 2024 |
|
| Vanguard Group | 2.9M | $24M | 46% | Mar 2024 |
|
| Soleus Capital Management | 2.5M | $20M | 34% | Mar 2024 |
|
| Balyasny Asset Management | 2.4M | $20M | 43% | Mar 2024 |
|
| T. Rowe Price Associates | 2.1M | $17M | -17% | Mar 2024 |
|
| Bank of America Corporation | 1.9M | $15M | 11% | Mar 2024 |
|
| Two Sigma Advisers | 1.3M | $11M | 1705% | Mar 2024 |
|
| Arrowpoint Asset Management | 1.3M | $11M | -40% | Mar 2024 |
|
| Goldman Sachs Group | 1.3M | $11M | 1029% | Mar 2024 |
|
| Two Sigma Investments | 1.2M | $9.6M | 100% | Mar 2024 |
|
| Bain Capital Life Sciences Investors | 1.1M | $9.3M | -30% | Mar 2024 |
|
| Susquehanna International | 1.1M | $9.1M | 587% | Mar 2024 |
|
| Point72 Asset Management | 907k | $7.4M | -54% | Mar 2024 |
|
| BlackRock | 905k | $7.4M | -57% | Mar 2024 |
|
| Rafferty Asset Management | 834k | $6.8M | 100% | Mar 2024 |
|
| Citigroup | 771k | $6.3M | 469% | Mar 2024 |
|
| Cubist Systematic Strategies | 765k | $6.2M | 146% | Mar 2024 |
|
| UBS Group | 697k | $5.7M | 150% | Mar 2024 |
|
| Dimensional Fund Advisors | 632k | $5.2M | 447% | Mar 2024 |
|
| Millennium Management | 575k | $4.7M | -24% | Mar 2024 |
|
| Citadel Advisors | 543k | $4.4M | 54% | Mar 2024 |
|
| Laurion Capital Management | 535k | $4.4M | 100% | Mar 2024 |
|
| Morgan Stanley | 514k | $4.2M | 64% | Mar 2024 |
|
| Geode Capital Management | 510k | $4.2M | 12% | Mar 2024 |
|
| D. E. Shaw & Co | 497k | $4.1M | 104% | Mar 2024 |
|
| Qube Research & Technologies | 388k | $3.2M | 5537% | Mar 2024 |
|
| Charles Schwab Investment Management | 267k | $2.2M | 6% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 174k | $1.4M | 4% | Mar 2024 |
|
| Marshall Wace | 147k | $1.2M | -87% | Mar 2024 |
|
| Man Group | 140k | $1.1M | -12% | Mar 2024 |
|
| Squarepoint Ops | 137k | $1.1M | 197% | Mar 2024 |
|
| Mariner Wealth Advisors | 128k | $1.0M | 0% | Mar 2024 |
|
| ProFund Advisors | 126k | $1.0M | 100% | Mar 2024 |
|
| Northern Trust | 109k | $888k | 19% | Mar 2024 |
|
| Engineers Gate Manager | 104k | $853k | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 102k | $830k | 100% | Mar 2024 |
|
| Harbor Capital Advisors | 97k | $792k | 28% | Mar 2024 |
|
| TD Asset Management | 93k | $758k | -2% | Mar 2024 |
|
| Susquehanna Portfolio Strategies | 91k | $745k | 100% | Mar 2024 |
|
| American Century Companies | 89k | $726k | 179% | Mar 2024 |
|
| Arete Wealth Advisors | 85k | $696k | 18% | Mar 2024 |
|
| M^T Bank Corporation | 85k | $693k | -39% | Mar 2024 |
|
| Capital Fund Management | 77k | $627k | 100% | Mar 2024 |
|
| Quest Partners | 64k | $523k | 100% | Mar 2024 |
|
| Marathon Trading Investment Management | 64k | $523k | 100% | Mar 2024 |
|
| Bellevue Group | 58k | $471k | -7% | Mar 2024 |
|
| Jane Street | 54k | $442k | -73% | Mar 2024 |
|
| Barclays | 53k | $434k | 22% | Mar 2024 |
|
| Susquehanna Fundamental Investments | 51k | $420k | 192% | Mar 2024 |
|
| Simplex Trading | 49k | $402k | -48% | Mar 2024 |
|
| Bridgeway Capital Management | 49k | $400k | -67% | Mar 2024 |
|
| GSA Capital Partners | 49k | $398k | 100% | Mar 2024 |
|
| Graham Capital Management | 47k | $388k | 100% | Mar 2024 |
|
| Fox Run Management | 42k | $341k | 100% | Mar 2024 |
|
| Mirae Asset Global Investments | 41k | $138k | 100% | Mar 2024 |
|
| E Fund Management | 39k | $322k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 39k | $319k | 139% | Mar 2024 |
|
| FMR | 37k | $305k | -69% | Mar 2024 |
|
| Hsbc Holdings | 30k | $171k | -8% | Dec 2023 |
|
| Deerfield Management Company | 29k | $234k | 100% | Mar 2024 |
|
| Farallon Capital Management | 28k | $229k | 100% | Mar 2024 |
|
| Algert Coldiron Investors | 28k | $158k | -46% | Dec 2023 |
|
| Walleye Trading | 27k | $221k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 24k | $0 | 4292% | Mar 2024 |
|
| Royce & Associates | 24k | $193k | -45% | Mar 2024 |
|
| SG Americas Securities | 22k | $183k | 100% | Mar 2024 |
|
| Acadian Asset Management | 22k | $179k | -21% | Mar 2024 |
|
| Polymer Capital Management | 22k | $179k | 100% | Mar 2024 |
|
| Caxton Associates | 21k | $172k | 100% | Mar 2024 |
|
| Stifel Financial | 20k | $164k | 100% | Mar 2024 |
|
| LMR Partners | 20k | $160k | 100% | Mar 2024 |
|
| Occudo Quantitative Strategies | 18k | $150k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 16k | $127k | 100% | Mar 2024 |
|
| Entropy Technologies | 15k | $126k | 100% | Mar 2024 |
|
| Captrust Financial Advisors | 15k | $121k | 0% | Mar 2024 |
|
| Principal Financial Group | 13k | $108k | -10% | Mar 2024 |
|
| CI Private Wealth | 13k | $104k | 0% | Mar 2024 |
|
| Lazard Asset Management | 12k | $69k | 100% | Dec 2023 |
|
| Quantbot Technologies | 10k | $84k | 78% | Mar 2024 |
|
| Tower Research Capital | 6.9k | $57k | -44% | Mar 2024 |
|
| Pacer Advisors | 3.9k | $32k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 1.8k | $15k | 0% | Mar 2024 |
|
| Aquatic Capital Management | 1.4k | $11k | 100% | Mar 2024 |
|
| Syntax Research | 1.0k | $8.2k | 0% | Mar 2024 |
|
| Cutler | 800.00 | $6.0k | -95% | Mar 2024 |
|
| Piscataqua Savings Bank | 600.00 | $4.9k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 358.00 | $2.9k | -73% | Mar 2024 |
|
| Efficient Wealth Management | 331.00 | $3.0k | 0% | Mar 2024 |
|
| Us Bancorp | 39.00 | $319.000500 | 100% | Mar 2024 |
|
| Coston, McIsaac & Partners | 23.00 | $0 | 21% | Mar 2024 |
|
| Jpmorgan Chase & Co | 6.00 | $49.000200 | -100% | Mar 2024 |
|
Who sold out of C4 Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AQR Capital Management | Dec 2023 | 149k | $840k |
| Schonfeld Strategic Advisors | Dec 2023 | 102k | $578k |
| Raymond James & Associates | Dec 2023 | 101k | $571k |
| Jacobs Levy Equity Management | Dec 2023 | 100k | $567k |
| XTX Topco | Sep 2023 | 96k | $179k |
| Bank Of Montreal | Dec 2023 | 77k | $463k |
| Ameriprise Financial | Sep 2023 | 70k | $129k |
| 683 Capital Management | Dec 2023 | 56k | $314k |
| Springbok Capital Management | Sep 2023 | 51k | $95k |
| CornerCap Investment Counsel | Dec 2023 | 46k | $262k |
| B. Metzler seel. Sohn & Co | Sep 2023 | 33k | $62k |
| Verition Fund Management | Sep 2023 | 31k | $58k |
| Bank of New York Mellon | Dec 2023 | 21k | $117k |
| Mirabella Financial Services | Dec 2023 | 18k | $104k |
| Sherbrooke Park Advisers | Dec 2023 | 11k | $63k |
| Shay Capital | Dec 2023 | 10k | $57k |
| FNY Investment Advisers | Dec 2023 | 8.8k | $49k |
| Headlands Technologies | Dec 2023 | 6.9k | $39k |
| Point72 Asia | Dec 2023 | 3.9k | $22k |
| Federated Investors | Sep 2023 | 3.1k | $5.8k |
| Northwestern Mutual Wealth Management Company | Sep 2023 | 2.6k | $4.9k |